Wenge Wang

机构：City of Hope · ORCID：0000-0001-9509-6735

发表论文 209 篇 · 总被引 6921 次 · h-index 39

代表论文

• AIROGS: Artificial Intelligence for Robust Glaucoma Screening Challenge (2023 · IEEE Transactions on Medical Imaging · 被引 89)
• A phase III, multicenter, randomized study of olvimulogene nanivacirepvec followed by platinum-doublet chemotherapy and bevacizumab compared with platinum-doublet chemotherapy and bevacizumab in women with platinum-resistant/refractory ovarian cancer (2023 · International Journal of Gynecological Cancer · 被引 30)
• Targeting PARG induces tumor cell growth inhibition and antitumor immune response by reducing phosphorylated STAT3 in ovarian cancer (2024 · Journal for ImmunoTherapy of Cancer · 被引 23)
• A phase I study of Mirvetuximab Soravtansine and gemcitabine in patients with FRα-positive recurrent ovarian, primary peritoneal, fallopian tube, or endometrial cancer, or triple negative breast cancer (2024 · Gynecologic Oncology · 被引 16)
• Impact of Sodium Thiosulfate on Prevention of Nephrotoxicities in HIPEC: An Ancillary Evaluation of Cisplatin-Induced Toxicities in Ovarian Cancer (2023 · Annals of Surgical Oncology · 被引 11)
• POLD1 DEDD Motif Mutation Confers Hypermutation in Endometrial Cancer and Durable Response to Pembrolizumab (2023 · Cancers · 被引 10)